chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Chest pain, Electrocardiogram, Fatigue, Magnetic resonance imaging head
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Oral disorder, Palpitations, Paraesthesia, Paraesthesia oral
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia, Pyrexia, Skin burning sensation, Tunnel vision, Vision blurred
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vitreous floaters
Clinical narrative: Extreme heart palpitations for 2.5 weeks (150-180 bpm); high blood pressure readings 134 - 180 mm Hg several times; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; vision disturbances such as floaters, light sensitivity, trouble focusing, and spots; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Batch/Lot Number: EW0153) as dose 1 single for covid-19 immunisation. Medical history included endometriosis from an unknown date and unknown if ongoing. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took bactrim and experienced drug allergy. On 10Apr2021 11:00, the patient experienced extreme heart palpitations for 2.5 weeks (150-180 bpm), high blood pressure readings 134 - 180 mm Hg several times, vision disturbances such as floaters, light sensitivity, trouble focusing, and spots. The patient received IV fluids, EKG (unknown result as reported), anti-anxiety medication as treatment. The events required Doctor or other healthcare professional office/clinic visit and visit to the Emergency room/ department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 - Abbott Rapid Test with negative result on 16Apr2021 (Nasal Swab). The outcome of the events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: The patient experienced unilateral lymphadenopathy of the chest on the same side the injection was administered.; This is a spontaneous report from a non-contactable consumer. An adult female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration, first and second dose both on an unknown date as single doses for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if patient was pregnant during vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced unilateral lymphadenopathy of the chest on the same side the injection was administered. The clinical outcome of the event lymphadenopathy was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: updated primary reporter additional qualification as none of the above,  first dose of bnt162b2 was removed from historical vaccine and added to suspect dose, vaccine date and event onset date were removed.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Product use issue, Pyrexia
Clinical narrative: Fever; Chills; Body aches; Headache; An other vaccine was received on same date 28Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration on 28Apr2021 (at the age of 42-year-old) at single dose for COVID-19 immunisation. An other vaccine was received on same date 28Apr2021. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient experienced fever, chills, body aches and headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was unknown. This report was reported as non-serious by reporter.  Information about lot/batch number cannot be obtained. No further information expected.  Amendment: This follow-up report is being submitted to amend previously reported information: event Product use for unapproved combination added since 'An other vaccine was received on same date 28Apr2021'.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Night sweats
Clinical narrative: difficult breathing,shortness of breath.; 2nd dose, night sweats, mid morning since  04/26/2021 to prevent.  Today 4:00 am sweats; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 71-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EP7533 and expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 at 12:00 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included renal transplant, hypotension, glaucoma, rubber sensitivity (known allergies: Latex (Rash)). The patient's concomitant medications were not reported. The patient had dose 1 of bnt162b2 on 05Apr2021 at 12:00 AM (lot Number: EP7533, vaccine location: Left arm). The patient experienced 2nd dose, night sweats, mid morning since 26Apr2021 to prevent. today 4:00 am sweats on 26Apr2021, difficult breathing,shortness of breath on 27Apr2021 at 04:00. Outcome of both the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Rash
Clinical narrative: No strength and weakness in arms. Notable the right arm.; Half dollar sized circles on arms, legs and face.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 29Apr2021 at 11:00 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history included circulation issues. Concomitant medications included methylphenidate hydrochloride (CONCERTA) and alprazolam (XANAX) started on an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Apr2021 at 18:30, the patient experienced half dollar sized circles on arms, legs and face; no strength and weakness in arms and was notable in the right arm. The clinical outcome of the event half dollar sized circles on arms, legs and face; no strength and weakness in arms and notable the right arm was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Fatigue, Headache, Nasal congestion
Clinical narrative: Stuffy nose; Loss of taste; headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Apr2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included vitamin D, ascorbic acid (VITAMIN C) and synthetic prenatal vitamin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received Ibuprofen and experienced allergy. The patient also previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021 at 13:00, the patient experienced stuffy nose, loss of taste, headache and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcomes of the events stuffy nose, loss of taste, headache and fatigue were not resolved.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Very little soreness in my left arm after the 2nd vaccine as compared to 1st.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 25-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO179) via an unspecified route of administration in the left arm on 01May2021 at 12:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. No medical history was reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021, the patient experienced soreness in left arm. The patient experienced very little soreness in her left arm after the second vaccine as compared to first. The patient was expecting more adverse effects. The clinical outcome of the event soreness in left arm was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Migraine, Nausea, Pain, Vaccination site warmth
Clinical narrative: migraine; slight burning in chest; body aches; warm/hot feeling on arm where the dose was administered; nauteous feeling; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 16:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient previously received  first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 17:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation and Buckwheat. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 06:00 the patient experienced migraine, slight burning in chest, body aches, warm/hot feeling on arm where the dose was administered, nauseous feeling which lasted most of the day, until around 19:00. The clinical outcome of the events migraine, slight burning in chest, body aches, warm/hot feeling on arm where the dose was administered and nauseous feeling was recovered on 01May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity, Peripheral swelling
Clinical narrative: Difficult to sleep; Both feet hurt; Feet were slightly swollen, but not discolored; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 24Apr2021 at 09:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient previously did not receive any medications. Concomitant medications included simvastatin (STATIN) taken for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021, Saturday morning, the patient received the shot. On 26Apr2021, Monday night, the patient noticed both his feet hurt. The patient's pain increased on Tuesday and Wednesday (28Apr2021) making it difficult to sleep on Wednesday. On Thursday and Friday, they hurt less but the patient still experienced a little hurt. The patient never had foot pain for any reason in the past, except after a long hike or other extreme exertion. The patient did not do anything unusual to make his feet hurt. On an unknown date in Apr2021, the patient's feet were slightly swollen, but not discolored and they were not sore to the touch. The clinical outcome of the events both feet hurt, making it difficult to sleep and feet were slightly swollen, but not discolored was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, SARS-CoV-2 test
Clinical narrative: Sore arm; slightly swollen two months after second vaccination; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Feb2021 at 10:30 (at the age of 77-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, blood pressure high and cholesterol. The past drug included ALEEVE for unknown indication, from an unknown date. The patient received unspecified medication within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Jan2021 at 10:00 (at the age of 77-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 23Feb2021 at 1900, the patient experienced sore arm and slightly swollen arm. The patient was concerned with length of time, since it continued to the present -May1. The events resulted in doctor or other healthcare professional office/clinic visit. On 01May2021, the patient underwent COVID test (nasal swab) and the result was negative. The clinical outcome of the event sore arm and swollen arm was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Skin discolouration
Clinical narrative: Swollen lymph node in underarm left side / swelling; Slight discoloration; Tenderness; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8736) via an unspecified route of administration in the left arm on 30Apr2021 at 09:45 (at the age of 54-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. On 01May2021 at 08:00, the patient experienced swollen lymph node in underarm left side, slight discoloration, swelling and tenderness. The clinical outcome of the events swollen lymph node in underarm left side, slight discoloration, swelling and tenderness were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Swollen lymph node under left arm.; Fever; Headache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 26Apr2021 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included tetanus vaccine (TETANUS) started from 21Apr2021 for an unknown indication and isotretinoin (ACCUTANE) from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 05Apr2021 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received any other vaccines within four weeks prior to the vaccination. On 01May2021 the patient experienced swollen lymph node under left arm. After lymph node swelling went down delayed reaction with headache, fever, body aches, 6 days after vaccination. The clinical outcomes of headache, fever, body aches were not recovered while that of swollen lymph node was recovered on an unknown date in May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Dyspnoea, Nausea, Parosmia
Clinical narrative: Certain food and drink have tasted extremely metallic; poop or fart, it smells like burnt hair/smoke/rubber; Very nauseating and concerning; had a really rough time breathing.Easily out of breath; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Apr2021 at 12:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and fluticasone propionate (FLONASE); from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Apr2021 at 14:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 22:00 the patient experienced certain food and drink have tasted extremely metallic, poop or fart/it smells like burnt hair/smoke/rubber, very nauseating and concerning, and also had a really rough time breathing and easily out of breath. The clinical outcome of the events tastes metallic, poop or fart/it smells like burnt hair/smoke/rubber, nausea, and a really rough time breathing and easily out of breath was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Fall, Hypoaesthesia, Muscular weakness, Unevaluable event
Clinical narrative: Knee hyperflexing; Lost nerve feeling and muscular control in right leg; Lost nerve feeling and muscular control in right leg; Fell back on right hip, tail bone and right wrist hard; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old, patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 14Apr2021 at 10:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history and past drug history. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021 at 23:15, the patient stood up from toilet, lost nerve feeling and muscular control in right leg, could feel knee hyperflexing so fell back on right hip, tail bone and right wrist hard. Therapeutic measures were not reported. The clinical outcome of events lost nerve feeling and muscular control in right leg, could feel knee hyperflexing so fell back on right hip, tail bone and right wrist hard were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Periorbital swelling
Clinical narrative: Swollen under my eyes.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 30Apr2021 at 10:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included dermal fillers a couple of months back and the patient reported no other relevant medical history. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN), both taken from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 09Apr2021 at 00:00 as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 08:00, the next day after the vaccination, the patient experienced swollen under her eyes and the patient called her doctor. Therapeutic measures were taken as a result of swollen under the eyes and included treatment with benadryl and ice as suggested by her doctor. The clinical outcome of the event swollen under her eyes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Gait disturbance
Clinical narrative: Severe back pain middle back left side; Severe back pain -middle back left side- that made it difficult to walk.; This is a spontaneous report from a contactable consumer, the patient. A 47 years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0173) via an unspecified route of administration in the left arm on 01May2021 at 08:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included meniere's disease. The patient received medication(unspecified) within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0158) via an unspecified route of administration in the right arm on 10Apr2021 at 08:30(at the age of 47-years-old) as a single dose for COVID-19 immunisation. It was reported that the patient previously received shrimp. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 09:30 about 1 hour after vaccination, the patient experienced severe back pain (middle back left side) that made it difficult to walk or even lay on that side for about 24 hours.  After 24 hours, the pain was less with ibuprofen and had slight pain for two days later but improving. The patient received treatment for the reported events which included treatment with ibuprofen.The clinical outcome of the event severe back pain and difficulty to walk was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration on 01May2021 at 11:15 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. It was unknown if the patient was diagnosed with COVID-19, prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced headache and sore arm. The clinical outcome of the events headache and sore arm was recovered on an unspecified date in May2021.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness within 12 hours of vaccination.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01May2021 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01May2021, the patient experienced arm soreness within 12 hours of vaccination. The clinical outcome of the event arm soreness within 12 hours of vaccination was recovered on an unknown date in May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Autoscopy, Chest pain, Dizziness, Feeling abnormal
Clinical narrative: Chest pain; Headache; muscle fatigue; joint pain; muscle pain; muscle cramps; arm soreness; dizziness; vertigo; blurry vision; tingly sensation in arm and leg; sharp toe pain; out of body experience; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 02May2021 at 14:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and acid reflux. The patient did not take any concomitant medications. The past drug history was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 18:45, the patient experienced chest pain, headache, muscle fatigue, joint pain, muscle pain and cramps, arm soreness, dizziness, vertigo, blurry vision, tingly sensation in arm and leg, sharp toe pain, out of body experience and brain fog. The clinical outcome of the events chest pain, headache, muscle fatigue, joint pain, muscle pain, muscle cramps, pain in arm, dizziness, vertigo, blurry vision, tingling sensation, pain in toe, out of body experience and foggy feeling in head were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscle fatigue, Muscle spasms, Myalgia, Pain in extremity
Clinical narrative: Chest pain; Headache; muscle fatigue; joint pain; muscle pain; muscle cramps; arm soreness; dizziness; vertigo; blurry vision; tingly sensation in arm and leg; sharp toe pain; out of body experience; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 02May2021 at 14:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and acid reflux. The patient did not take any concomitant medications. The past drug history was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 18:45, the patient experienced chest pain, headache, muscle fatigue, joint pain, muscle pain and cramps, arm soreness, dizziness, vertigo, blurry vision, tingly sensation in arm and leg, sharp toe pain, out of body experience and brain fog. The clinical outcome of the events chest pain, headache, muscle fatigue, joint pain, muscle pain, muscle cramps, pain in arm, dizziness, vertigo, blurry vision, tingling sensation, pain in toe, out of body experience and foggy feeling in head were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Vertigo, Vision blurred
Clinical narrative: Chest pain; Headache; muscle fatigue; joint pain; muscle pain; muscle cramps; arm soreness; dizziness; vertigo; blurry vision; tingly sensation in arm and leg; sharp toe pain; out of body experience; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 02May2021 at 14:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension and acid reflux. The patient did not take any concomitant medications. The past drug history was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 18:45, the patient experienced chest pain, headache, muscle fatigue, joint pain, muscle pain and cramps, arm soreness, dizziness, vertigo, blurry vision, tingly sensation in arm and leg, sharp toe pain, out of body experience and brain fog. The clinical outcome of the events chest pain, headache, muscle fatigue, joint pain, muscle pain, muscle cramps, pain in arm, dizziness, vertigo, blurry vision, tingling sensation, pain in toe, out of body experience and foggy feeling in head were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24Mar2021 at 18:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. Concomitant medications included multi-vitamin, blood pressure, cholesterol and allerg for unknown indications and from an unknown date. The patient previously received sulphur (reported as sulfer) for unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021 the patient experienced hives. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of hives and included treatment with famotidine (PEPCID). The clinical outcome of the event hives was not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Circumstance or information capable of leading to medication error, Respiration abnormal
Clinical narrative: far as the second shot goes, it seemed to her that maybe it would be a good idea to reschedule a little farther out, wait one moths or two months; chest feels somewhat compressed and breathing is not normal; chest feels somewhat compressed and breathing is not normal; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 16Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The caller stated she had her first Pfizer Covid vaccine on 16Apr2021 and scheduled a second shot for 03May2021. She stated she had no problem with the first shot, and she was planning on getting the second one, over the course of the days in between, nothing serious that would make her to go running to a doctor, stated her chest felt somewhat compressed and her breathing was not precisely normal. She further stated the thing is it was not enough to be concerning to do anything about but as far as the second shot goes, it seemed to her that maybe it would be a good idea to reschedule a little farther out, wait one month or two months to isolate what she was feeling. She was asking if it was okay to postpone her second dose. The outcome of the events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac stress test, Chest X-ray, Chest discomfort, Dizziness, Electrocardiogram
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175), via an unspecified route of administration in the left arm on 27Apr2021 at 15:00(at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included scoliosis. The patient did not take any concomitant medications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 07:00, the patient experienced tightness in heart area which began the day after the vaccine. The tight sensation would come and go. During the day when the patient was moving around it would go away. The tight, heavy sensation returned during sleeping hours and the patient would feel it in the morning when woke up. It would dissipate when the patient moved around during the day and return again. On 30Apr2021, three days after the injection, the patient woke up with the heavy, tight feeling and it became worse around 10:00 and the patient became light headed and the arms and hands tingled. The patient called the doctor and they told to go to the ER. The patient went to the hospital where they did a chest X-ray, EKG, and a stress test. The results from all of the tests showed a healthy heart. The events resulted in emergency room/department visit or urgent care. On 30Apr2021, the patient underwent chest X-ray, EKG and stress test and the results were unknown. The clinical outcome of the events tightness in heart was recovering and the clinical outcome of the events light headed and arms and hand tingled were unknown. No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175), via an unspecified route of administration in the left arm on 27Apr2021 at 15:00(at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included scoliosis. The patient did not take any concomitant medications.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 07:00, the patient experienced tightness in heart area which began the day after the vaccine. The tight sensation would come and go. During the day when the patient was moving around it would go away. The tight, heavy sensation returned during sleeping hours and the patient would feel it in the morning when woke up. It would dissipate when the patient moved around during the day and return again. On 30Apr2021, three days after the injection, the patient woke up with the heavy, tight feeling and it became worse around 10:00 and the patient became light headed and the arms and hands tingled. The patient called the doctor and they told to go to the ER. The patient went to the hospital where they did a chest X-ray, EKG, and a stress test. The results from all of the tests showed a healthy heart. The events resulted in emergency room/department visit or urgent care. On 30Apr2021, the patient underwent chest X-ray, EKG and stress test and the results were unknown. The clinical outcome of the events tightness in heart was recovering and the clinical outcome of the events light headed and arms and hand tingled were unknown. No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Thermal burn
Clinical narrative: burn; itching; Rash on R posterior thigh; This is a spontaneous report from a contactable nurse. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162), via intramuscular route of administration in the arm right on 16Apr2021(at the age of 50-year-old), as a single dose for COVID-19 immunisation. Medical history included ADHD (attention deficit-hyperactivity disorder), prediabetes, degenerative disc disease of L-spine, premenstrual dysphoric disorder, premenstrual dysphoric disorder, depression, anxiety and had chicken pox as a child. Concomitant medications were not reported. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730), via intramuscular route of administration in the arm left on 26Mar2021 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 27Apr2021, the patient experienced itching and rash on right posterior thigh (skin rash). The patient denied altered sensation or pain in that area prior to rash. That continued to itch and burn. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included treatment with valacyclovir hydrochloride (MANUFACTURER UNKNOWN) 1g per 1 tablet by mouth three times daily for 7 days. The clinical outcome of the events itching and rash on right posterior thigh was unknown.   No follow-up attempts are needed. No further information is expected.